Impact Factor
2.47
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.29
104 total citations
h5-index
12
h5 depth signal
Cited share
51.7%
46 of 89
Total citations
104
Citation footprint
Metric signal
1.07
External metric anchor
Self-citation
5.8%
6 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
152
China
95
India
55
Turkey
50
Iran
43
Citing Fields of Research
HIV
476
Immunology
51
Virology
30
Hepatitis
18
Lymphomas
17
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,462
Articles tracked across the journal lifetime
Indexed publication set
89
46 cited publications
Last 12 months
62
6.2 publications/month
Open access share
24.2%
15 OA publications in the last year
Leading citing country
United States
152 citing publications
Leading citing field
HIV
476 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan. 2003-
v1n1, Jan. 2003-
Active Coverage
Research Focus & Classification
Indexed Subjects
HIV
Broad Categories
Acquired Immunodeficiency Syndrome
HIV
MeSH Descriptors
AIDS Vaccines
Anti-HIV Agents
HIV Infections
HIV
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.2174/011570162x511442260930192119
Open DOI
A Multivariate Statistics Approach to Analyze the Transition from CCR5 to Dual and CXCR4 Tropism and to Predict the Coreceptor Usage of HIV-1
Background: The tropism of HIV-1 is determined by the use of either or both chemokine coreceptors CCR5 (R5) and CXCR4 (X4) for entry into the target cell. The coreceptor usage of HIV-1 is mainly determined by the third variable loop (V3)...
02
DOI 10.2174/011570162x512390260928094143
Open DOI
Elucidating the Distribution of Time Since Infection Among Individuals with Undiagnosed HIV Infection in Japan
Introduction: Understanding the characteristics of undiagnosed HIV is essential for targeted testing and anticipating severe cases. This study quantified the time distribution since infection among individuals with undiagnosed HIV infect...
03
DOI 10.2174/011570162x507829261004183336
Open DOI
Proportion and Characteristics of Primary HIV Infection Among Newly Diagnosed Individuals in Istanbul
Introduction: Early identification of Primary HIV İnfection (PHI) is essential to reduce onward transmission and enable prompt initiation of Antiretroviral Therapy (ART). Despite increasing HIV diagnoses in Türkiye, data on the prevalenc...
04
DOI 10.2174/011570162x493354260909092534
Open DOI
Factors Associated with HIV Infection in MSM Visiting Bathhouses: A Structural Equation Model Analysis of a Cross-Sectional Survey in Eastern China
Objectives: This study aimed to explore the factors associated with Human Immunodeficiency Virus (HIV) infection among men who have sex with men (MSM) during bathing activities to provide a basis for developing comprehensive intervention...
05
DOI 10.2174/011570162x478765260909062929
Open DOI
Alterations in Th17/Treg Balance and IL-21 Signaling in Patients with HIV and Mycobacterium tuberculosis Coinfection
Introduction/Objective: This study aimed to characterize the distributions of Th17 and regulatory T (Treg) cells and the associated interleukin-21 (IL-21) signaling in patients with human immunodeficiency virus (HIV) and Mycobacterium tu...
06
DOI 10.2174/011570162x506228260917112128
Open DOI
Comparison of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin with Other Serum Biomarkers for Bone Homeostasis in People Living with HIV
Introduction: This study evaluated Bone Mineral Density (BMD) and examined the associations of serum Receptor Activator of Nuclear factor kappa-B Ligand (RANKL), Osteo-protegerin (OPG), and the RANKL/OPG ratio with Dual-energy X-ray Abso...
07
DOI 10.2174/011570162x471413260831044324
Open DOI
24-Month Outcomes of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV from the Italian BICSTaR Cohort
Introduction: The Italian BICSTaR cohort is part of a multinational cohort study as-sessing real-world effectiveness, safety, persistence, and patient-reported outcomes (PROs) of B/F/TAF in treatment-naïve (TN) and treatment-experienced ...
08
DOI 10.2174/011570162x486285260904055900
Open DOI
Western Blot Band Profiles and Their Associations with Demographic Characteristics, Transmission Routes, and Immune Status among HIV-1 Infected Individuals in Quzhou, China (2016-2024)
Objective: This study investigated the associations between Western blot (WB) band profiles and demographic characteristics, transmission routes, and immune status among 737 newly diagnosed HIV-1-infected individuals in Quzhou City, Chin...
09
DOI 10.2174/011570162x529595260831071004
Open DOI
Assessment of Depression and Associated Factors in People Living with HIV: A Cross-Sectional Study Using the Beck Depression Inventory
Introduction: This study aimed to determine the prevalence of depression among people living with Human Immunodeficiency Virus (HIV) and to examine the sociodemographic, clinical, and immunologic factors associated with depressive sympto...
10
DOI 10.2174/011570162x485799260831045019
Open DOI
Non-Invasive Serum Biomarkers Used to Stage Liver Fibrosis in Brazilian HIV/HCV-Coinfected Individuals
Background: HIV/HCV coinfection accelerates liver fibrosis progression and increases liver-related morbidity and mortality. In Brazil, where chronic liver diseases remain a major public health concern and access to specialized diagnostic...
Bibliographical & Catalog Notes
Title from cover.
Latest issue consulted: Vol. 1, no. 2 (Apr. 2003).
Also issued online.